All News



News From January 2019

By: Chris Perkins   Topics: License, TechAdvance
Published: January 28, 2019

Rutgers University has partnered with Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, to develop a new technique built on CRISPR.

Originally developed by Shengkan "Victor" Jin, associate professor of pharmacology in the Robert Wood Johnson Medical School at Rutgers, and Juan Carlos Collantes, currently a pharmacology postdoctoral fellow, the technique allows for safer and more effective gene editing than existing CRISPR methods, and has the potential to develop new therapies for sickle cell anemia, HIV, leukemia and more.